Company profile
Newtec Vascular Products Limited
Newtec Vascular Products Ltd A UK based Medical Device Innovation Company
Newtec Vascular Products Limited is a UK company with status active founded in 2013 based in North West England.
Corporate ownership
Updated 06 Jun 2026 16:52
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Termination Director Company With Name Termination Date
OfficersTM01 | Transaction MzQ0MzY2MTA4NmFkaXF6a2N4
Published 17 Nov 2024 07:05
Accounts With Accounts Type Total Exemption Full
Accounts Awaiting analysisAA | Transaction MzQzNzY3NjY0OGFkaXF6a2N4
Published 30 Sep 2024 08:05
Accounts filed
AccountsLast accounts made up date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
KOLLAGUARD
1 Oct 2021 to 30 Jun 2024
‘StentSeal’ – an innovative vascular surgery device to prevent ‘endoleaks’ in endovascular stent-graft placement
1 Oct 2019 to 28 Feb 2021
The aorta is the largest artery in the body, leading from the heart down to the abdomen. Atherosclerosis (a common condition where arteries become clogged with plaques, causing them to harden and narrow) weakens and thins the vessel walls and aneurysms can occur, which can rupture, causing massive internal bleeding and rapid death if left untreated. The s...
VascuLok – A novel, safe and secure vessel ligating system
1 Mar 2018 to 31 Aug 2019
"Clip devices are widely used in surgery where the occlusion/ligation of vessels is required. Mechanical ligation of the vessel using clip devices can offer major advantages including early ambulation and decreased hospital resource utilisation; however, they are also associated with incidences of bleeding through device failure and other more significant...
Development of an innovative medical device to promote healthy blood flow in bypass surgery
1 Aug 2015 to 31 Mar 2017
Cardiovascular diseases (CVD) account for ~31% of all global deaths. Atherosclerosis - hardening & narrowing of the arteries thus restricting blood supply to essential organs - is the dominant cause of CVD responsible for ~75% of all cardiovascular deaths. Surgeons perform complex bypass graft surgery using sections of a patient’s own healthy vessels or s...